Autres langues VBI Vaccines Inc.

Actions

VBIV

CA91822J2020

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
0,571 ^USD	+1,24%		-6,16%	-2,81%

16/04	VBI Vaccines Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
03/04	VBI Vaccines Inc. présente des données encourageantes sur la réponse tumorale précoce de l'étude randomisée et contrôlée de phase 2b sur le VBI-1901 dans le glioblastome récurrent	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

VBI Vaccines : 2023 Annual Report	17/04
VBI Vaccines Reports Full Year 2023 Financial Results	16/04
VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
North American Morning Briefing : Stock Futures -2-	15/04
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	11/04
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	09/04
North American Morning Briefing : Inflation Data, -2-	08/04
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03/04
VBI Vaccines Inc. Presents Encouraging Early Tumor Response Data from Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03/04
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform - VBI Vaccines	03/04
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform	02/04
VBI Vaccines Inc. Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA- Launched eVLP Vaccine Platform	02/04
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results	25/03
North American Morning Briefing : Tech in Focus on -2-	25/03
North American Morning Briefing : Investors -2-	18/03
North American Morning Briefing : Stock Futures -2-	11/03
Brii Biosciences Announces Agreements To Acquire VBI Vaccines' IP Rights In BRII-179	05/03
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo Capital?	15/02
VBI Vaccines Sells Rights to Hepatitis B Vaccine to Brii Biosciences	14/02
VBI Vaccines Inc. Enter into New License Agreement with Brii Biosciences	14/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues VBI Vaccines Inc.

Actions

VBIV

CA91822J2020

Autres langues

Filtres